PharmaJet partner Zydus Cadila submits data to DCGI for world's first plasmid DNA-based COVID-19 vaccine....delivered needle-free. Contacts Nancy Lillie Nancy.Lillie@pharmajet.com 1-888-900-4321 ...

Shares of Cadila Healthcare Ltd jumped 7.9% on Monday after India last week approved the drugmaker's COVID-19 vaccine, the world's first DNA shot against the coronavirus, for emergency use in ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila, is partnering with Enzychem Lifesciences to ...

Cadila Pharmaceuticals announced the launch of the world's first aqueous formulation of cholecalciferol, setting a new benchmark in the treatment of Vitamin D deficiency. This ground-breaking ...

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory ...

Zydus Cadila is planning to produce 10 million doses per month of its COVID-19 vaccine, to begin with, and subsequently raise it to 20 million doses.

Zydus Cadila's needle-free COVID-19 vaccine 'ZyCoV-D' will be the sixth Covid vaccine to be available in India.

Meanwhile, talks are underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D. The pharma company is learnt to have proposed a price of ₹ 1,900 ...

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different tablet products that were cross-contaminated with API residue from another drug ...

Cadila didn’t say what the warning letter criticized, but it didn’t have to. The plant was savaged in a 14-observation Form 483 issued in May. The citation listed a range of problems from ...

Indian drugmaker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of ...

India's Cadila Healthcare Ltd has received a U.S. Food and Drug Administration (FDA) warning letter for violating manufacturing standards at two of its production facilities, the latest in a ...